Product category:
Genomics
News Release from: GATC Biotech
Edited by the Laboratorytalk Editorial
Team on 11 March 2008
GATC Biotech opens subsidiary in
Stockholm
GATC Biotech has added to its facilities with a wholly owned subsidiary in Stockholm, Sweden, building on the company's existing presence in Europe with offices in Germany, France, and England
The new subsidiary will provide expanded sales and support services in Scandinavia in order to meet growing demand for GATC Biotech's services GATC Biotech saw rapid expansion during 2007, increasing its production capacity from 15.6 to 250 gigabases per year and growing from 45 employees at the end of 2006 to 62 by the end of 2007
This article was originally published on Laboratorytalk on 3 May 2007 at 8.00am (UK)
Related stories
Nine bacterial genomes sequenced in a month
GATC Biotech says its scientists sequenced nine bacterial genomes in April 2007, demonstrating the capabilities of its technology portfolio and expertise in high throughput genome sequencing
Human genome sequencing service launched
GATC is the first sequencing company worldwide to offer whole human genome sequencing to industry and academia and aims to deliver, in ten years, a quality dataset for euro500
In November last year, GATC Biotech announced the launch of its human genome sequencing service, and in January founded subsidiary company LifeCode.
LifeCode is the first web-based information service for the storage and utilisation of biological and medical data for the analysis of genetic codes and protein codes in the EU.
Further recruitment during the first quarter of this year demonstrates the company's commitment to sustained development.
The company says it is the only sequencing service provider in the world to have all leading sequencing technologies (Solid, GS FLX and Genome analyser) in-house.
Katarina Nystroem, sales manager at the Stockholm office, said: "We are focused on providing a personalised and efficient service for our customers.
"The decision to open a subsidiary in Stockholm will enable GATC Biotech to be closer to our rapidly developing Scandinavian client base".
Peter Pohl, CEO of GATC Biotech, commented: "I'm delighted to announce the opening of the Stockholm office.
"The addition of this new subsidiary and increase in services and production capacity will serve to strengthen the company's position as the leading sequencing service provider in Europe.".
• GATC Biotech: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
